ARTICLE | Clinical News
Immunomedics regulatory update
December 21, 1998 8:00 AM UTC
The FDA approved the company's Morris Plains, N.J., manufacturing facility and manufacturing process for its CEA-Scan arcitumomab diagnostic imaging product. Prior, IMMU manufactured products at its ...